Roots Analysis has done a detailed study on Next Generation Sequencing Kits Market, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 200+ page report, which features 70+ figures and 120+ tables, please visit this https://www.rootsanalysis.com/reports/next-generation-sequencing-kits-market/free-insights.html
Key Market Insights
§ Presently, more than 280 NGS library preparation kits are being offered by close to 60 players; these kits are compatible with a variety of input samples, including purified RNA / DNA and cells
§ Leveraging their expertise, stakeholders within this domain are offering a myriad of NGS kits for preparing DNA and RNA libraries; majority of such kits require less than 5 ng of input samples
§ The current market landscape is fragmented, featuring both new entrants and established players; the US is currently considered to be a hub of innovation related to NGS library preparation kits
§ In pursuit of gaining a competitive edge, NGS library preparation kit providers are presently focusing on expansion of their existing capabilities and augmenting their respective product portfolios
§ Around 3,250 patents related to NGS library preparation kits have recently been filed / granted, indicating the heightened pace of innovation in this domain
§ Case Study: Around 70 industry players claim to offer elaborate portfolios of NGS based services, leveraging a variety of second and third generation sequencing technologies
§ The market is anticipated to grow at a CAGR of 18%, till 2035, and the projected opportunity is likely to be distributed across different type of nucleotide sequenced, end user and key geographical regions
For more information, please visit https://www.rootsanalysis.com/reports/next-generation-sequencing-kits-market.html
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Genome Sequencing
3.3. Types of Genome Sequencing
3.3.1. Next Generation Sequencing
3.3.1.1. Applications of Next Generation Sequencing
3.3.1.1.1. Cancer and Affiliated Biomarker Research
3.3.1.1.2. Diagnostics
3.3.1.1.3. Personalized / Precision Medicine
3.3.1.1.4. Forensics
3.3.1.2. Steps Involved in Next Generation Sequencing
3.3.1.2.1. Library Preparation
3.3.1.2.2. Amplification
3.3.1.2.3. Sequencing
3.3.1.2.4. Bioinformatics Analysis and Data Interpretation
3.3.1.3. Components of Next Generation Sequencing Kits
3.4. Future Perspectives
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Next Generation Sequencing Kits: Overall Market Landscape
4.2.1. Analysis by Type of Nucleotide Sequenced
4.2.2. Analysis by Kit Components
4.2.3. Analysis by Quantity of Sample Required
4.2.4. Analysis by Turnaround Time
4.2.5. Analysis by Storage Temperature
4.2.6. Analysis by Type of Sample Used
4.2.7. Analysis by Kit Shelf Life
4.2.8. Analysis by Type of Sequencing
4.2.9. Analysis by Type of Sequencing Platform Used
4.3. Next Generation Sequencing Kits: List of Providers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Leading Players: Analysis by Number of Products
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Methodology
5.3. Product Competitiveness Analysis: Competitive Landscape
6. COMPANY PROFILES: NEXT GENERATION SEQUENCING KITS PROVIDERS IN NORTH
AMERICA
6.1. Chapter Overview
6.2. Agilent Technologies
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. NGS Kit Portfolio
6.2.4. Recent Developments and Future Outlook
6.3. BioDynami
6.3.1. Company Overview
6.3.2. NGS Kit Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Creative Biogene
6.4.1. Company Overview
6.4.2. NGS Kit Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. New England Biolabs
6.5.1. Company Overview
6.5.2. NGS Kit Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. PerkinElmer
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. NGS Kit Portfolio
6.6.4. Recent Developments and Future Outlook
6.7. Thermo Fisher Scientific
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. NGS Kit Portfolio
6.7.4. Recent Developments and Future Outlook
7. COMPANY PROFILES: NEXT GENERATION SEQUENCING KITS PROVIDERS IN EUROPE
7.1. Chapter Overview
7.2. Abcam
7.2.1 Company Overview
7.2.2. Financial Information
7.2.3. NGS Kit Portfolio
7.2.4. Recent Developments and Future Outlook
7.3. Devyser
7.3.1 Company Overview
7.3.2. NGS Kit Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. Diagenode
7.4.1 Company Overview
7.4.2. NGS Kit Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. Lexogen
7.5.1 Company Overview
7.5.2. NGS Kit Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. Roche
7.6.1 Company Overview
7.6.2. Financial Information
7.6.3. NGS Kit Portfolio
7.6.4. Recent Developments and Future Outlook
7.7. Tecan
7.7.1 Company Overview
7.7.2. Financial Information
7.7.3. NGS Kit Portfolio
7.7.4. Recent Developments and Future Outlook
8. COMPANY PROFILES: NEXT GENERATION SEQUENCING KITS PROVIDERS IN ASIA
PACIFIC
8.1. Chapter Overview
8.2. Enzynomics
8.2.1. Company Overview
8.2.2. NGS Kit Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. MGI
8.3.1. Company Overview
8.3.2. &n
